You are viewing an incomplete version of our website. Please click to reload the website as full version.

Goat anti-Human IgG (Fc Region) Antibody

Details for Product No. ABIN101643, Supplier: Log in to see
Antigen
Epitope
Fc Region
4276
1867
1731
962
643
277
203
56
35
34
31
8
8
5
3
3
2
2
2
2
2
1
1
1
1
1
1
Reactivity
Human
2413
2318
2036
1524
1260
609
562
382
328
296
296
291
290
224
162
112
105
76
32
24
21
13
12
8
5
5
5
4
4
4
4
4
4
4
4
3
3
3
2
2
1
1
Host
Goat
6020
4115
1527
600
545
262
85
49
43
8
8
4
4
3
1
1
Clonality
Polyclonal
Application
Immunoassay (IA)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen Human IgG fragment
Specificity IgG F(c)
Characteristics Concentration Definition: by Refractometry
Purification This product was prepared from monospecific antiserum by a delipidation and defibrination. Assay by immunoelectrophoresis resulted in a single precipitin arc against Human IgG, Human IgG F (c) and Human Serum.
Research Area Immunology, Secondary Antibodies
Application Notes Optimal working dilutions should be determined experimentally by the investigator.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Restore with deionized water (or equivalent)
Concentration 31.0 mg/mL
Buffer 0.01 M Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Background publications Reimer, Phillips, Aloisio et al.: "Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes." in: Hybridoma, Vol. 3, Issue 3, pp. 263-75, 1985 (PubMed).

Papadea, Check, Reimer: "Monoclonal antibody-based solid-phase immunoenzymometric assays for quantifying human immunoglobulin G and its subclasses in serum." in: Clinical chemistry, Vol. 31, Issue 12, pp. 1940-5, 1986 (PubMed).

Robinson, White, Mason: "Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3." in: Immunology, Vol. 57, Issue 2, pp. 239-47, 1986 (PubMed).

Fahraeus R, Fu HL, Ernberg I et al.: "Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma." in: Int J Cancer, Vol. 42, Issue 3, pp. 329-38, 1988 (PubMed).

Rowe, Evans, Young et al.: "Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells." in: The Journal of general virology, Vol. 68 ( Pt 6), pp. 1575-86, 1987 (PubMed).

Jarrett, Gallagher, Jones et al.: "Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age." in: Journal of clinical pathology, Vol. 44, Issue 10, pp. 844-8, 1992 (PubMed).